Maximus, Inc. (NYSE:MMS – Get Free Report) was the target of a significant growth in short interest in November. As of November 15th, there was short interest totalling 1,270,000 shares, a growth of 64.3% from the October 31st total of 773,200 shares. Currently, 2.1% of the shares of the stock are short sold. Based on an average daily volume of 528,200 shares, the short-interest ratio is presently 2.4 days.
Maximus Price Performance
NYSE:MMS opened at $74.50 on Friday. The company has a market capitalization of $4.49 billion, a P/E ratio of 14.90 and a beta of 0.77. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.59. Maximus has a 52 week low of $71.75 and a 52 week high of $93.97. The stock’s fifty day moving average is $86.50 and its two-hundred day moving average is $87.57.
Maximus Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Saturday, November 30th. Shareholders of record on Friday, November 15th were paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.61%. The ex-dividend date was Friday, November 15th. Maximus’s dividend payout ratio (DPR) is presently 24.00%.
Wall Street Analysts Forecast Growth
View Our Latest Report on Maximus
Insider Activity
In other news, insider Michelle F. Link sold 1,363 shares of the business’s stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $92.56, for a total transaction of $126,159.28. Following the transaction, the insider now owns 6,567 shares of the company’s stock, valued at approximately $607,841.52. The trade was a 17.19 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.40% of the company’s stock.
Institutional Investors Weigh In On Maximus
Institutional investors have recently made changes to their positions in the stock. V Square Quantitative Management LLC acquired a new stake in Maximus in the 3rd quarter valued at approximately $25,000. GAMMA Investing LLC raised its holdings in shares of Maximus by 224.5% in the 2nd quarter. GAMMA Investing LLC now owns 344 shares of the health services provider’s stock valued at $29,000 after buying an additional 238 shares during the period. Blue Trust Inc. grew its position in Maximus by 201.5% in the 2nd quarter. Blue Trust Inc. now owns 392 shares of the health services provider’s stock valued at $33,000 after acquiring an additional 262 shares in the last quarter. Archer Investment Corp increased its stake in Maximus by 8,788.9% during the second quarter. Archer Investment Corp now owns 800 shares of the health services provider’s stock worth $69,000 after purchasing an additional 791 shares during the period. Finally, Ariadne Wealth Management LP acquired a new stake in shares of Maximus during the second quarter worth about $90,000. 97.21% of the stock is currently owned by institutional investors and hedge funds.
About Maximus
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also
- Five stocks we like better than Maximus
- 3 REITs to Buy and Hold for the Long Term
- ServiceNow: Will the High-Flyer Finally Split in 2024?
- What is the Euro STOXX 50 Index?
- MarketBeat Week in Review – 11/25 – 11/29
- Short Selling: How to Short a Stock
- These 3 Stocks Are Heavy Hitters in Alternative Asset Management
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.